Elsevier

Advanced Drug Delivery Reviews

Volume 124, 15 January 2018, Pages 16-33
Advanced Drug Delivery Reviews

A slippery slope: On the origin, role and physiology of mucus

https://doi.org/10.1016/j.addr.2017.10.014Get rights and content

Abstract

The mucosa of the gastrointestinal tract, eyes, nose, lungs, cervix and vagina is lined by epithelium interspersed with mucus-secreting goblet cells, all of which contribute to their unique functions. This mucus provides an integral defence to the epithelium against noxious agents and pathogens. However, it can equally act as a barrier to drugs and delivery systems targeting epithelial passive and active transport mechanisms. This review highlights the various mucins expressed at different mucosal surfaces on the human body, and their role in creating a mucoid architecture to protect epithelia with specialized functions. Various factors compromising the barrier properties of mucus have been discussed, with an emphasis on how disease states and microbiota can alter the physical properties of mucus. For instance, Akkermansia muciniphila, a bacterium found in higher levels in the gut of lean individuals induces the production of a thickened gut mucus layer. The aims of this article are to elucidate the different physiological, biochemical and physical properties of bodily mucus, a keen appreciation of which will help circumvent the slippery slope of challenges faced in achieving effective mucosal drug and gene delivery.

Introduction

The mucosal barriers of the human body are integral not only to protect against immunological, chemical and mechanical stresses, but have also increasingly gained prominence for their key role in drug delivery. Mucosa consists of one or more layers of epithelial cells overlying a layer of loose connective tissue, the lamina propria; which is a key part of the mucosal immune system, and followed by the submucosa, consisting of submucosal glands and muscular layers. Some specialized mucosal epithelial cells (such as goblet cells) secrete mucus glycoproteins, which form a layer of viscoelastic mucus on the surface of epithelia. Mucus per se is a semi-permeable network that enables the exchange of nutrients, water, gases, hormones and gametes, whilst being impermeable to most bacteria and pathogens due to its steric obstruction and adhesion properties [1], [2]. Cell surface mucins are a prominent feature of the apical glycocalyx of all mucosal epithelia [3].

The properties and functions of mucus secretions are adapted to suit the anatomical location, and can change (as cause or consequence) in disease states where mucus hypersecretion or altered mucin expression is observed [3], [4]. Indeed, the differing compositions of the mucosa and mucus of the eye, nose, lower respiratory tract, gastrointestinal tract, cervix and vagina are all individually unique and adapted to perform the functions of these barriers seamlessly, whilst simultaneously protecting the underlying epithelium. For instance, the epithelia of the respiratory tract form a mucociliary escalator [4] that aids the movement and expulsion of trapped inhaled foreign bodies, whereas the transmembrane mucins tethered in the periciliary layer (PCL) form a sieve restricting particles > 40 nm from translocating into the PCL, thereby maintaining sterility [5], [6]. In turn, a double-layer mucus architecture in the hostile zones of the stomach and colon protect the underlying lining from acid, enzymes (pepsin and proteases) and microbial aggressors [7], [8]. Endogenous hormone secretion from the epithelia of the cervix and vagina also changes the viscoelasticity of cervical mucus in different stages of the menstrual cycle, to either promote or prevent conception [9]. Dietary influences have also been observed to modulate the colonic mucus; low-fibre diets, for instance, have been shown to lead to thinning of mucus owing to associated bacterial colonization [10], [11]. This thinning exposes the epithelium to bacterial contact and translocation into the mucosa, eliciting an immunological response and further damage and inflammation, as seen in ulcerative colitis [12]. These properties of mucus in the healthy state, however, make it an excellent guard against immunological as well as chemical and mechanical damage, thereby allowing the mucosa to carry out its normal physiological functions.

While mucus precludes the permeation of drugs, proteins, peptides and nanoparticulate drug delivery systems [13], [14], certain capsid viruses have been observed to diffuse through cervicovaginal mucus at rates similar to that in water [15], implying that this barrier cannot restrict surface neutral particles from reaching and infecting the epithelium. Additionally, the mucus pore size and rheology also influence this phenomenon [16]. This property has been exploited towards the design of muco-inert polyethylene glycol coated nanoparticles that are muco-penetrating for cervico-vaginal and ocular delivery [17], [18]. Overall, this knowledge can be used to design drug delivery systems to diffuse ‘upstream’ against the secretion and shedding of mucus to deliver drugs to epithelia.

Furthermore, mucus secreting epithelia continuously secrete and turnover mucus to create a physiological clearance mechanism. However, this protective mechanism can also cause undesirable drug clearance, a common barrier to drug delivery. As such, in order to deliver the drug payload, and hence achieve the desired drug exposure, prolonged contact of the formulation at the target site is desirable. Mucoadhesive systems have been employed by virtue of their ability to interact with the mucin glycoprotein; whereby mucoadhesive excipients by swelling and interdiffusion of the polymer chains bond with mucin fibres through hydrogen bonding, disulfide bonding, electrostatic and/or hydrophobic interactions. An in-depth review of mucoadhesion as a concept to increase residence time is beyond the scope of this review which focuses on the physiological aspects of mucosa and mucus and therefore the following references [19], [20], [21], [22], [23] will provide the reader with greater insight in the area of mucoadhesion.

This article reviews the mucosal histology in relation to the arrangement of goblet cells and submucosal glands. The biosynthesis and release mechanism of mucin from the goblet cells and the physiological and mechanical characteristics of the mucus lining different epithelia are here discussed. Additionally, the functionality of the mucus lining and its dynamic composition are discussed in their role of health and disease.

Section snippets

Mucosa and mucus: histological, biosynthetic, biochemical and rheological overview

The mucosal epithelium is interspersed with goblet cells which secrete mucus and protect the epithelial cells. If antigenic materials translocate through the epithelium, it triggers an immune response in the underlying lamina propria and submucosa which can comprise the connective tissues of the mucosa [24], [25]. The immune response is characterized by inflammation and epithelial destruction, exacerbating the damage. Therefore, mucus serves as a tenacious semipermeable barrier allowing only

The slippery slope: variations in mucus along the gastrointestinal (GI) tract

The gastrointestinal wall is composed of four different layers: the mucosa, the submucosa, the muscularis and the serosa. The mucosa is further subdivided into three main layers: the muscularis mucosa, lamina propria and the epithelium. The mucus largely establishes the first barrier for absorption through the gastrointestinal tract. Fig. 3 illustrates the mucus architecture along the gastrointestinal tract of humans.

Sweeping the dirt away: mucosa and mucus of the respiratory tract

The nasal cavity has an anterior chamber, the nasal vestibule which is followed by the respiratory tract which is highly folded providing a high surface area to volume ratio. The nasal vestibule consists of keratinized stratified squamous epithelial cells and the respiratory regions consisting of the inferior, middle and superior turbinates are made of pseudostratified ciliated columnar cells (Fig. 5) with microvilli and cilia thereby providing an area of 120 cm2 [131]. This region produces the

Is the cervical and vaginal mucus similar?

The cervix connects the vagina with the uterus and functioning as an entrance into the female endometrial and abdominal cavities. Therefore, a protection mechanism has to be in place to avoid external microorganisms to gain access. The vagina wall is structured in a lamina propria and an epithelium of non-cornified stratified squamous cells. The thickness of this epithelial barrier is higher in puberty and after menopause. The luminal pH decreases after puberty to about pH 4–5, depending on the

Protecting the sclera: the pre-corneal tear film and conjunctival epithelium

The eye (Fig. 6) is covered by a wet surface epithelium over coating the cornea, conjunctiva and other inner surfaces, which has similar functions as other wet surfaces, including lubrication, protection against damage, fluid loss and pathogens infection [209], [210]. The epithelium of the cornea also plays a role in the transmission of light and refraction. The tear film is composed by an outer lipid layer and by the inner aqueous layer which is composed by anti-bacteria proteins and mucins.

Conclusion

This review has served to highlight the adaptations of mucosal surfaces and mucus to promote their optimal and healthy functioning. Factors including mucus hydrophobicity, viscoelasticity, turnover and thickness, as well as epithelial dynamics (such as mucociliary clearance in the respiratory tract) work together to enable mucus to function as a tenacious semi-permeable barrier. However, this useful mucus barrier can also create a slippery slope of challenges to mucosal drug and gene delivery

Acknowledgements

We thank Atheer Awad for assisting with the technicalities involved in preparing the graphical abstract.

Funding source

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflicts of interest

None.

References (240)

  • S. Knoblaugh et al.

    3 - Necropsy and histology A2 - Treuting, Piper M

  • G.M.H. Birchenough

    New developments in goblet cell mucus secretion and function

    Mucosal Immunol.

    (2015)
  • J.D. Long et al.

    Esophageal submucosal glands: structure and function

    Am. J. Gastroenterol.

    (1999)
  • E.P. Lillehoj

    Cellular and Molecular Biology of Airway Mucins

    (2013)
  • K. Netsomboon et al.

    Mucoadhesive vs. mucopenetrating particulate drug delivery

    Eur. J. Pharm. Biopharm.

    (2016)
  • C. Ridley

    Assembly of the respiratory mucin MUC5B: a new model for a gel-forming mucin

    J. Biol. Chem.

    (2014)
  • C. Ehre et al.

    Cystic fibrosis: an inherited disease affecting mucin-producing organs

    Int. J. Biochem. Cell Biol.

    (2014)
  • G.M.H. Birchenough

    New developments in goblet cell mucus secretion and function

    Mucosal Immunol.

    (2015)
  • J.R. Gum

    Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor

    J. Biol. Chem.

    (1994)
  • V.L. Murty

    Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein

    Biochem. Biophys. Res. Commun.

    (1984)
  • C. Taylor

    Two rheologically different gastric mucus secretions with different putative functions

    Biochim. Biophys. Acta Gen. Subj.

    (2004)
  • J.A. Nicolazzo et al.

    Buccal penetration enhancers—how do they really work?

    J. Control. Release

    (2005)
  • I. Diaz del Consuelo

    Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue

    J. Pharm. Sci.

    (2005)
  • S.K. Linden

    Mucins in the mucosal barrier to infection

    Mucosal Immunol.

    (2008)
  • T.L. Gururaja

    Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1

    Biochim. Biophys. Acta

    (1999)
  • W. Meyer

    Keratinization of the esophageal epithelium of domesticated mammals

    Acta Histochem.

    (2014)
  • J. Dixon

    Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett's esophagus

    Am. J. Gastroenterol.

    (2001)
  • S.B. Ho

    Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression

    Gastroenterology

    (1995)
  • G.L.H. Wong

    High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori–negative idiopathic bleeding ulcers

    Gastroenterology

    (2009)
  • E.L. McConnell et al.

    Gut instincts: explorations in intestinal physiology and drug delivery

    Int. J. Pharm.

    (2008)
  • A.C. Freire

    Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery

    Int. J. Pharm.

    (2011)
  • G.B. Hatton

    Animal farm: considerations in animal gastrointestinal physiology and relevance to drug delivery in humans

    J. Pharm. Sci.

    (2015)
  • M. Boegh et al.

    Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties

    Basic Clin. Pharmacol. Toxicol.

    (2015)
  • L.M. Ensign

    Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues

    Mol. Pharm.

    (2013)
  • B. Button

    A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia

    Science

    (2012)
  • X. Murgia

    Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics

    Eur. J. Nanomed.

    (2014)
  • M.E.V. Johansson

    The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria

    Proc. Natl. Acad. Sci. U. S. A.

    (2008)
  • A. Allen et al.

    Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin

    Am. J. Physiol. Cell Physiol.

    (2005)
  • E. Linford

    Cervical mucus: an agent or a barrier to conception?

    J. Reprod. Fertil.

    (1974)
  • H.J. Flint

    Microbial degradation of complex carbohydrates in the gut

    Gut Microbes

    (2012)
  • L.E. Tailford

    Mucin glycan foraging in the human gut microbiome

    Front. Genet.

    (2015)
  • M.E.V. Johansson

    Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis

    Gut

    (2014)
  • A. Bernkop-Schnürch et al.

    Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration

    Pharm. Pharmacol. Commun.

    (1996)
  • Q. Xu

    Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo

    ACS Nano

    (2015)
  • F.J. Varum

    Mucoadhesion and the gastrointestinal tract

    Crit. Rev. Ther. Drug Carrier Syst.

    (2008)
  • N. Washington et al.

    Physiological Pharmaceutics: Barriers to Drug Absorption

    (2002)
  • M. Vareille

    The airway epithelium: soldier in the fight against respiratory viruses

    Clin. Microbiol. Rev.

    (2011)
  • B. Macao

    Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin

    Nat. Struct. Mol. Biol.

    (2006)
  • M.E.V. Johansson

    Fast renewal of the distal colonic mucus layers by the surface goblet cells as measured by in vivo labeling of mucin glycoproteins

    PLoS One

    (2012)
  • F.A. Meyer et al.

    Structure and Function of Mucus

    (2008)
  • Cited by (0)

    This review is part of the Advanced Drug Delivery Reviews theme issue on “Technological strategies to overcome the mucus barrier in mucosal drug delivery”

    View full text